GlassScriptPhysician profile
Todd P Chapman
NPI 1326011685
$2,570.45
in general payments reported to CMS, 2019-2025
12 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $176 · 2021: $53.17 · 2022: $37.39 · 2023: $236 · 2024: $1,613 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,174 · Travel and Lodging: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.99 |
| Travel and Lodging | $998.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,708.71 | 2024-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $149.96 | 2023 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $142.80 | 2020-2024 | Xarelto |
| Abiomed | $131.84 | 2019 | |
| Edwards Lifesciences Corporation | $114.52 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Mitris Resilia Mitral Valve |
| Silk Road Medical, INC. | $101.74 | 2020 | |
| Novartis Pharmaceuticals Corporation | $56.44 | 2020-2021 | |
| Madrigal Pharmaceuticals | $49.19 | 2025 | Rezdiffra |
| Abbott Laboratories | $46.38 | 2021-2025 | Perclose Prostyle |
| Heartflow, INC. | $37.39 | 2022 | |
| Merck Sharp & Dohme LLC | $19.26 | 2021 | |
| Amgen INC. | $12.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.